SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lincoln Pharmaceuticals’ board to consider merger of Lincoln Parenteral

11 Sep 2019 Evaluate

Lincoln Pharmaceuticals' board is planning to consider and approve draft scheme of amalgamation of its subsidiary -- Lincoln Parenteral (The Transferor Company) with Lincoln Pharmaceuticals (The Transferee Company). The company’s board at their meeting to be held on September 19, 2019, to consider the same.

Lincoln Pharmaceuticals is engaged in the manufacture and marketing of affordable therapeutic products. The product range of the company includes Tablets, Capsules, Injectable, Syrups and Ointments.

Lincoln Pharma Share Price

592.15 -0.65 (-0.11%)
16-Apr-2026 14:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1684.75
Dr. Reddys Lab 1225.20
Cipla 1229.95
Zydus Lifesciences 936.15
Lupin 2313.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×